ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,473.23
      0.77%
      US Tech 100
      19,408.75
      1.26%
      Dow Jones
      38,778.10
      0.49%
      Brent Oil
      83.785
      -0.14%
      Bitcoin
      65,443.65
      -1.57%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. DMK Pharmaceuticals Corporation (DMK)

      7. DMK Pharmaceuticals Corporation (DMK) News

      DMK

      DMK Pharmaceuticals (DMK)

      DMK Pharmaceuticals Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:DMK
      DateTimeSourceHeadlineSymbolCompany
      03/21/20242:23PMEdgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
      02/07/20245:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
      02/06/202410:04AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DMKDMK Pharmaceuticals Corporation
      02/05/20249:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
      01/31/20245:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
      01/23/20245:23PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
      01/23/20245:22PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
      01/03/20245:03PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
      01/03/20245:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
      01/03/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
      12/21/202312:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
      12/21/20238:15AMGlobeNewswire Inc.DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHINASDAQ:DMKDMK Pharmaceuticals Corporation
      12/04/20234:47PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
      12/04/20234:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
      11/28/20234:41PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
      11/28/20238:05AMGlobeNewswire Inc.DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate UpdateNASDAQ:DMKDMK Pharmaceuticals Corporation
      11/15/20234:39PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
      11/15/20234:20PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
      11/15/20234:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
      11/15/20234:06PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
      11/14/20233:57PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
      11/14/20237:30AMGlobeNewswire Inc.DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DMKDMK Pharmaceuticals Corporation
      11/13/202310:52AMGlobeNewswire Inc.DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023NASDAQ:DMKDMK Pharmaceuticals Corporation
      11/02/20234:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
      11/02/20234:31PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
      10/30/20237:30AMGlobeNewswire Inc.DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DMKDMK Pharmaceuticals Corporation
      10/25/20235:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
      10/25/20235:01PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
      10/20/20234:15PMGlobeNewswire Inc.DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DMKDMK Pharmaceuticals Corporation
      10/19/20235:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
       Showing the most relevant articles for your search:NASDAQ:DMK

      Your Recent History

      NYSE
      JZZ
      Lehman Abs 6.75
      Delayed Upgrade Clock